Tonix Pharma (NASDAQ: TNXP) reported Q2 EPS of ($3.86), $2.97 better than the analyst estimate of ($6.83). Revenue for the quarter came in at $2 million versus the consensus estimate of $2.55 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.